TR201902845T4 - Artritik durumların karakterize edilmesine yönelik bileşimler ve yöntemler. - Google Patents

Artritik durumların karakterize edilmesine yönelik bileşimler ve yöntemler. Download PDF

Info

Publication number
TR201902845T4
TR201902845T4 TR2019/02845T TR201902845T TR201902845T4 TR 201902845 T4 TR201902845 T4 TR 201902845T4 TR 2019/02845 T TR2019/02845 T TR 2019/02845T TR 201902845 T TR201902845 T TR 201902845T TR 201902845 T4 TR201902845 T4 TR 201902845T4
Authority
TR
Turkey
Prior art keywords
compositions
methods
arthritic conditions
characterizing
characterizing arthritic
Prior art date
Application number
TR2019/02845T
Other languages
English (en)
Inventor
Marotta Anthony
Original Assignee
Augurex Life Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Augurex Life Sciences Corp filed Critical Augurex Life Sciences Corp
Publication of TR201902845T4 publication Critical patent/TR201902845T4/tr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Mevcut buluş, 14-3-3 proteinlerine karşı otoantikorlar veya bunların dolaşan immün kompleksleri ve bir artritik durumun teşhisi ve prognozuna yönelik bunların saptanması ile ilgilidir.
TR2019/02845T 2009-03-11 2010-03-11 Artritik durumların karakterize edilmesine yönelik bileşimler ve yöntemler. TR201902845T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15938609P 2009-03-11 2009-03-11

Publications (1)

Publication Number Publication Date
TR201902845T4 true TR201902845T4 (tr) 2019-03-21

Family

ID=42727761

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/02845T TR201902845T4 (tr) 2009-03-11 2010-03-11 Artritik durumların karakterize edilmesine yönelik bileşimler ve yöntemler.

Country Status (16)

Country Link
US (2) US11054419B2 (tr)
EP (1) EP2406633B1 (tr)
JP (1) JP5792637B2 (tr)
KR (1) KR101894597B1 (tr)
CN (1) CN102414563B (tr)
AU (1) AU2010223776B2 (tr)
BR (1) BRPI1009573A2 (tr)
CA (1) CA2754741C (tr)
DK (1) DK2406633T3 (tr)
ES (1) ES2714216T3 (tr)
HU (1) HUE043684T2 (tr)
IL (1) IL215056A (tr)
PL (1) PL2406633T3 (tr)
PT (1) PT2406633T (tr)
TR (1) TR201902845T4 (tr)
WO (1) WO2010102412A1 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2768851T (pt) * 2011-10-21 2017-09-08 Augurex Life Sciences Corp Antigénios derivados de 14-3-3 citrulinada e utilizações dos mesmos no diagnóstico de artrite reumatoide
CN114397442A (zh) * 2018-01-05 2022-04-26 科美诊断技术股份有限公司 检测14-3-3eta蛋白的均相免疫检测试剂盒及其应用
AU2019264996A1 (en) * 2018-05-10 2020-11-26 The Methodist Hospital Methods for prognosis and management of disease
CN110579600B (zh) * 2018-05-23 2023-12-26 科美诊断技术股份有限公司 通过生物标记物联检体外评估类风湿性关节炎是否存在的方法
CN110531073B (zh) * 2018-05-23 2024-03-15 科美诊断技术股份有限公司 通过生物标记物联检体外评估类风湿性关节炎是否存在的方法
CN110579597A (zh) * 2018-05-23 2019-12-17 科美诊断技术股份有限公司 检测14-3-3 eta蛋白的非均相化学发光免疫检测试剂盒及其应用
CN110579601B (zh) * 2018-05-24 2023-12-26 科美诊断技术股份有限公司 通过生物标记物联检体外评估类风湿性关节炎是否存在的方法
CN110726843A (zh) * 2018-07-16 2020-01-24 科美诊断技术股份有限公司 检测14-3-3eta蛋白的化学发光免疫检测试剂盒及其应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956281A (en) * 1987-06-03 1990-09-11 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing lymphocyte function associated antigen-3
US6596476B1 (en) * 1989-12-22 2003-07-22 Abbott Laboratories Hepatitis C assay
US5948765A (en) 1996-03-15 1999-09-07 Washington University Inhibition of intracellular signal transduction by 14-3-3-binding peptides
US5998149A (en) 1996-04-05 1999-12-07 The United States Of America As Represented By The Department Of Health And Human Services Method of detecting transmissible spongiform encephalopathies
US5814507A (en) 1996-05-24 1998-09-29 Genentech, Inc. κ/μ-like protein tyrosine phosphatase, PTP λ
WO1998026293A1 (en) 1996-12-12 1998-06-18 Neuromark Methods of detecting transmissible spongiform encephalopathies by detecting 14-3-3 protein isoforms
US20020173454A1 (en) * 2000-01-31 2002-11-21 Rosen Craig A. Nucleic acids, proteins, and antibodies
US7011952B2 (en) * 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
AU2001245838A1 (en) 2000-03-17 2001-10-03 Gemini Science, Inc. Soluble mast cell function associated antigen (mafa) pharmaceutical compositionsand methods of making and using them
KR100380147B1 (ko) 2001-01-18 2003-04-11 주식회사 엘지생명과학 류마티스성 자가면역 항체의 검출방법 및 검출키트
WO2002067968A2 (en) 2001-02-21 2002-09-06 Emory University 14-3-3 binding molecules as sensitizers for anticancer therapies
EP1322957B1 (en) * 2001-05-04 2009-08-12 Biosite Incorporated Diagnostic markers of acute coronary syndromes and methods of use thereof
DE10131912A1 (de) 2001-06-06 2002-12-19 Werner E G Mueller Verwendung von 14-3-3 Proteinen und Verfahren zu deren Bestimmung
US7171311B2 (en) 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
US7172905B2 (en) * 2001-08-07 2007-02-06 The University Of Chicago Polypeptide immobilization
GB0208331D0 (en) 2002-04-11 2002-05-22 Oxford Glycosciences Uk Ltd Proteins
US7101962B2 (en) 2003-05-15 2006-09-05 Bristol-Myers Squibb Company Antibodies of the P2Y10 receptor useful in altering T lymphocyte function
CA2533618A1 (en) 2003-06-25 2004-12-29 Queen's University At Kingston Methods for diagnosing, monitoring, staging and treating heart failure
JP4790624B2 (ja) 2003-11-21 2011-10-12 ジョンズ ホプキンス ユニバーシティ 生体分子パーティションモチーフ及びそれらの使用
TWI281473B (en) 2003-12-19 2007-05-21 Ind Tech Res Inst Biomarkers for liver diseases and method for using same
US7396654B2 (en) 2004-04-15 2008-07-08 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for traumatic brain injury
US20070253961A1 (en) 2004-06-09 2007-11-01 Ulsan Industrial Education Foundation Pharmaceutical Composition Comprising the Anti-4-1Bb Antibody for Treating or Preventing Rheumatoid Arthritis
GB2426581A (en) * 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
GB2428240A (en) 2005-07-14 2007-01-24 Univ Gen Ve Diagnostic method for brain damage-related disorders
PL2021792T3 (pl) * 2006-05-09 2013-08-30 Univ British Columbia Rozpuszczone białkowe markery zapalenia stawów
JP2010540960A (ja) 2007-10-03 2010-12-24 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド インスリン様成長因子−１受容体キナーゼ阻害剤に対する抗癌反応を予測する生物学的マーカー
WO2009046267A1 (en) 2007-10-05 2009-04-09 University Of Virginia Patent Foundation Protein-based biomarkers for abdominal aortic aneurysm
US7919262B2 (en) 2007-11-07 2011-04-05 The Uab Research Foundation 14-3-3 proteins for diagnosis of Parkinson's disease
JP5615181B2 (ja) * 2007-11-27 2014-10-29 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア 関節炎の予防及び治療のための組成物及び方法
WO2009097584A1 (en) 2008-01-30 2009-08-06 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
CA2725548A1 (en) * 2008-05-09 2009-11-12 Duke University Autoantibodies in the detection and treatment of cancer
SG186953A1 (en) 2010-07-09 2013-02-28 Somalogic Inc Lung cancer biomarkers and uses thereof
CN103429753A (zh) 2010-09-27 2013-12-04 私募蛋白质体公司 间皮瘤生物标记及其用途

Also Published As

Publication number Publication date
IL215056A (en) 2015-10-29
IL215056A0 (en) 2011-11-30
KR101894597B1 (ko) 2018-10-04
BRPI1009573A2 (pt) 2017-07-18
US11054419B2 (en) 2021-07-06
EP2406633B1 (en) 2019-01-16
US20210333276A1 (en) 2021-10-28
AU2010223776B2 (en) 2016-08-25
EP2406633A1 (en) 2012-01-18
ES2714216T3 (es) 2019-05-27
CA2754741C (en) 2019-02-12
PL2406633T3 (pl) 2019-07-31
CA2754741A1 (en) 2010-09-16
PT2406633T (pt) 2019-03-14
US20120058498A1 (en) 2012-03-08
HUE043684T2 (hu) 2019-09-30
DK2406633T3 (en) 2019-04-01
JP2012519860A (ja) 2012-08-30
JP5792637B2 (ja) 2015-10-14
WO2010102412A1 (en) 2010-09-16
EP2406633A4 (en) 2012-08-29
CN102414563B (zh) 2014-12-03
KR20120004990A (ko) 2012-01-13
CN102414563A (zh) 2012-04-11
AU2010223776A1 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
TR201902845T4 (tr) Artritik durumların karakterize edilmesine yönelik bileşimler ve yöntemler.
CY1122676T1 (el) Αντισωματα εναντι της κλαυδινης 18.2 που ειναι χρησιμα στη διαγνωση του καρκινου
CY1117784T1 (el) Μεθοδοι και συνθεσεις για διαγνωση και προγνωση νεφρικης βλαβης και νεφρικης ανεπαρκειας
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
WO2014160499A3 (en) Methods and compositions for detecting pancreatic cancer
EP2577300A4 (en) MULTIFUNCTIONAL PARTICLE SCANNING
EA201591740A1 (ru) Вирусы болезни ньюкасла и их применение
MA34521B1 (fr) Polypeptides de relaxine modifiés et leurs utilisations
GB201308243D0 (en) High-throughput immune sequencing
EA201491541A1 (ru) АНТИТЕЛА ПРОТИВ ИНТЕГРИНОВ αvβ6 И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ ЗЛОКАЧЕСТВЕННЫХ НОВООБРАЗОВАНИЙ
EA201390149A1 (ru) Способы выявления заболевания или патологических состояний с использованием фагоцитарных клеток
EP3734280A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011088385A3 (en) Compositions and methods for detecting cancer
EA201201000A1 (ru) Способы лечения колоректального рака
BR112014012590A8 (pt) Anticorpos anti-cd98 e métodos de uso dos mesmos
MY159553A (en) Detection and treatment of pancreatic, ovarian and other cancers
HK1200037A1 (en) Non-invasive methods of detecting target molecules
PH12013500240A1 (en) Biomarker assays for detecting or measuring inhibition of tor kinase activity
MX2023012628A (es) Metodos y composiciones para deteccion y diagnostico de enfermedades renales y enfermedades periodontales.
WO2015070001A3 (en) Compositions and methods for detecting and/or treating inflammation
MX336280B (es) Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal.
EA201891002A1 (ru) Иммунологический анализ для определения расщепленного высокомолекулярного кининогена
MX2014000283A (es) Metodos y composiciones para diagnóstico y pronóstico de lesión e insuficiencia renal.
WO2011116209A3 (en) Using phage epitopes to profile the immune response
BR112016003058A2 (pt) composições e métodos para análise multiplex de ácidos nucleicos nras e braf